Charles D. Thompson

1.3k citations

39 papers · 877 indexed · h-index 18

Cellular and Molecular Neuroscience top 10%
- Neuroscience and Neuropharmacology Research 11
- Neuropeptides and Animal Physiology 7
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 6
Toxicology top 5%
Oncology
- Peptidase Inhibition and Analysis 7
Molecular Biology
- Receptor Mechanisms and Signaling 11
- Pharmacological Receptor Mechanisms and Effects 5
- Signaling Pathways in Disease 4
Organic Chemistry
- Synthesis and biological activity 4

Co-authors: Timothy L. Macdonald William Westlin Gerhard Hannig Marion Wittmann George D. Hartman Matthew A. Seager Mark T. Bilodeau Scott D. Kuduk
Cited by: Cellular and Molecular Neuroscience Pharmacology Toxicology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of The Electrochemical Society (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States India United Kingdom

In The Last Decade

Charles D. Thompson

39 papers receiving 848 citations

Peers

Countries citing papers authored by Charles D. Thompson

Since Specialization

Citations

This map shows the geographic impact of Charles D. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Thompson more than expected).

Fields of papers citing papers by Charles D. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Thompson. The network helps show where Charles D. Thompson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles D. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles D. Thompson Line = papers co-authored together Charles D. Thompson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis Clinical Pharmacokinetics ·Terra M. Kruger,Belén Valenzuela,Charles D. Thompson,Sivi Ouwerkerk‐Mahadevan,Juan José Pérez Ruixo	2023	6
2	Bladder calculi causing irreducible urogenital prolapse BMJ Case Reports ·Charles D. Thompson,Bennett E Henderson,Russell Stanley	2018	6
3	Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Jonathan R. Saffold,William J. Ray,Lei Ma,Marion Wittmann,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau,Douglas C. Beshore	2014	7
4	Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform Molecular Pharmaceutics ·Yan Xu,Mei Ou,Ed Keough,Jeff Roberts,Ken Koeplinger,Mike Lyman,Scott Fauty,Ed Carlini,Melissa Stern,Rena Zhang,Suzie Yeh,Elizabeth Mahan,Yì Wáng,Don Slaughter,Marian E. Gindy,Conrad E. Raab,Charles D. Thompson,Jerome Hochman	2014	30
5	Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity Drug Metabolism and Disposition ·Christopher C. Arico-Muendel,Bruce Belanger,Dennis R. Benjamin,Heather Blanchette,Teresa Caiazzo,Jennifer L. DeLorey,Elisabeth Doyle,Ulrike Gradhand,Sarah T. Griffin,Susan E. Hill,Matthew Labenski,Barry A. Morgan,Gary O’Donovan,Kavirayani R. Prasad,Steven R. Skinner,Nazbeh Taghizadeh,Charles D. Thompson,James Wakefield,William Westlin,Kerry White	2013	9
6	Discovery of selective glucocorticoid receptor modulator MK-5932 Bioorganic & Medicinal Chemistry ·Christopher J. Bungard,George D. Hartman,Jesse J. Manikowski,James J. Perkins,Chang Bai,Philip E. Brandish,Danielle H. Euler,James C. Hershey,Azriel Schmidt,Yulin Fang,Ryan Norcross,Tom Rushmore,Charles D. Thompson,Robert Meißner	2011	16
7	Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Ronald K. Chang,Christina N. Di Marco,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2011	20
8	N-Heterocyclic derived M1 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Victoria Cofre,Daniel R. Pitts,William J. Ray,Lei Ma,Marion Wittmann,Lone Veng,Matthew A. Seager,Kenneth Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2010	25
9	Fused heterocyclic M1 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Victoria Cofre,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2010	14
10	Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Robert M. DiPardo,Douglas C. Beshore,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2010	15
11	Heterocyclic fused pyridone carboxylic acid M1 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Ronald K. Chang,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2010	21
12	Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Victoria Cofre,Daniel R. Pitts,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	2009	20
13	An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis Inflammation Research ·Douglas Lazarus,Elisabeth Doyle,S. G. Bernier,Ashley Rogers,Matthew Labenski,James Wakefield,Russell Karp,Eddie Clark,Jeanine Lorusso,Jennifer Hoyt,Charles D. Thompson,Gerhard Hannig,William Westlin	2008	11
14	Methionine aminopeptidases type I and type II are essential to control cell proliferation Journal of Cellular Biochemistry ·Sylvie G. Bernier,Nazbeh Taghizadeh,Charles D. Thompson,William Westlin,Gerhard Hannig	2005	59
15	A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis Proceedings of the National Academy of Sciences ·Sylvie G. Bernier,Douglas Lazarus,Edward J. Clark,Beth Doyle,Matthew Labenski,Charles D. Thompson,William Westlin,Gerhard Hannig	2004	84
16	Mechanisms of idiosyncratic drug reactions: the case of felbamate Chemico-Biological Interactions ·Christine M. Dieckhaus,Charles D. Thompson,Shane Roller,Timothy L. Macdonald	2002	57
17	The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate Drug Metabolism and Disposition ·Charles D. Thompson,Thomas A. Miller,Mary T. Barthen,Christine M. Dieckhaus,R. Duane Sofia,Timothy L. Macdonald	2000	14
18	The synthesis and evaluation of temperature sensitive tubulin toxins Bioorganic & Medicinal Chemistry Letters ·Thomas A. Miller,Amanda L. Bulman,Charles D. Thompson,Timothy L. Macdonald	1999	1
19	The synthesis and evaluation of benzannelated-azatoxins: The benzazatoxins Bioorganic & Medicinal Chemistry Letters ·Thomas A. Miller,Prakash Vachaspati,Marc Labroli,Charles D. Thompson,Amanda L. Bulman,Timothy L. Macdonald	1998	10
20	Mechanisms of Adrenergic Agonist Induced Allergy Bioactivation and Antigen Formation Experimental Eye Research ·Charles D. Thompson,Timothy L. Macdonald,Michael E. Garst,Anne G. Wiese,Stephen A. Munk	1997	18

About Charles D. Thompson

Charles D. Thompson is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Oncology, having authored 39 papers that have together received 877 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers), Peptidase Inhibition and Analysis (7 papers), Neuropeptides and Animal Physiology (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Synthesis and biological activity (4 papers) and Signaling Pathways in Disease (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (268 citations), Pharmacology (109 citations) and Toxicology (36 citations). Charles D. Thompson has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Timothy L. Macdonald, William Westlin, Gerhard Hannig, Marion Wittmann, George D. Hartman, Matthew A. Seager, Mark T. Bilodeau, Scott D. Kuduk, Sylvie G. Bernier and William J. Ray. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of The Electrochemical Society and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact